| Spirig HealthCare AG - Mometason Spirig HC 0.05 mg/Sprühstoss, Dosier Nasenspray |
| 67641 | | 01 | | Mometason Spirig HC 0.05 mg/Sprühstoss | | Dosier Nasenspray | | R01AD09 | | Mometasone | | 14.05.2020 | | |
|
| Composition |
| mometasoni-17 furoas monohydricus 0.5173 mg, benzalkonii chloridum 0.20 mg, glycerolum, polysorbatum 80, cellulosum microcristallinum et carmellosum natricum, acidum citricum monohydricum, natrii citras anhydricus, aqua purificata ad suspensionem pro 1 g corresp. mometasoni-17 furoas 50 µg pro dosi, doses pro vase 140. |
| Packungsbestandteile |
| Dosier Nasenspray | | | | | | | | | BAG: Active Agent | Dose |
|---|
| Mometasone 17 Furoate | 0.05 mg |
| | | | Inactive agents | Dose |
|---|
| Citric Acid Monohydrate | | | Benzalkonium Chloride | 0.2 mg/g | | Carmellose Sodium | | | Cellulosum Microcristallinum | | | Glycerol | | | Mometasoni-17 Furoas Monohydricus | 0.5173 mg/g | | Natrii Citras Anhydricus | | | Polysorbatum 80 | |
| |
|
|
